This association was only apparent among postmenopausal women (1.16; 0.98–1.62) but not among premenopausal women (0.83; 0.48–1.42) and among women who had estrogen receptor-positive breast cancer (1.22; 1.01–1.47) [26]. This evidence concerns the gene ESR1 and breast carcinoma.